Preparation method for Ivabradine

A technology of compound and addition salt, applied in the field of preparation of ivabradine

Inactive Publication Date: 2010-07-07
BEIJING D VENTUREPHARM TECH DEV
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The two-step reactions of the above-mentioned route all use precious metal palladium-carbon as a catalyst, and both use au

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for Ivabradine
  • Preparation method for Ivabradine
  • Preparation method for Ivabradine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: 3-(3-hydroxypropyl)-7,8-dimethoxy-4,5-dihydro-1H-benzazepine-2(3H)-one 2.3g3-(3- Hydroxypropyl)-7,8-dimethoxy-1H-benzazepine-2(3H)-one and 1.8g 10% Pd / C were added to 20mL methanol, and then slowly introduced into the system h 2 , so that the bubbles in the system are uniform. Heat the system to react at 40°C for 24h. Pd / C was recovered by suction filtration, and the filtrate was rotary evaporated to obtain 1.97 g of white solid, yield: 85%, melting point 102.5°C. 1H-NMR (CDCl 3 , 400MHz), δ1.72-1.75(t, 2H), 3.05-3.08(t, 2H), 3.48-3.51(t, 2H), 3.58-3.61(t, 2H), 3.71-3.74(q, 2H) , 3.84-3.85 (d, 8H), 6.57-6.60 (d, 2H). The NMR picture is attached figure 1

Embodiment 2

[0036] Embodiment 2: the hydrochloride preparation of ivabradine

[0037] 0.4g 3-(3-hydroxypropyl)-7,8-dimethoxy-4,5-dihydro-1H-benzazepin-2(3H)-one and 0.3g (S)-( 4,5-dimethoxy-1,2-dihydrobenzocyclobutyl-1-yl)-N-methylmethanamine was added to 10 mL of acetone, and then 0.2 g KI and 0.5 g K 2 CO 3 , started stirring and heated to reflux. The reaction was stopped after 24 h of reaction. Suction filtration, the filtrate was spin-dried to obtain a viscous solid, the solid was dispersed in water, and a filter cake was obtained by suction filtration, and the filtrate was discarded. It was then dissolved in ethyl acetate, washed with 3N HCl solution, adjusted to pH 7-8 with sodium hydroxide solution, dried over anhydrous magnesium sulfate, and rotary evaporated under reduced pressure to obtain an oily substance. The oil was dispersed in ethyl acetate to form monohydrochloride, and recrystallized from methanol and acetone to obtain 0.5 g of white crystalline powder with a yield o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method for Ivabradine. Catalytic hydrogenation is carried out on a formula (II) compound to obtain a formula (III) compound, reaction is carried out between the formula (III) compound and a formula (IV) compound under the action of base catalysis, and a catalyst is removed through filtration and separated to obtain the target compound.

Description

technical field [0001] The present invention relates to the synthesis of ivabradine of formula (I), i.e. 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octane-1,3,5-tri En-7-yl]-methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine- A method for preparing 2-ketone, and a pharmaceutically acceptable acid addition salt thereof. [0002] Background technique [0003] Ivabradine and its addition salts with pharmaceutically acceptable acids, more particularly its hydrochloride, possess extremely valuable pharmacological and therapeutic properties, especially bradycardic properties, making these compounds For the treatment or prophylaxis of various clinical conditions of myocardial ischemia such as angina pectoris, myocardial infarction and related arrhythmias, as well as various pathological conditions involving arrhythmias, especially supraventricular arrhythmias and heart failure. [0004] The preparation method of ivabradine and its hydrochloride has bee...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D223/16
Inventor 王春霞卢文张志强
Owner BEIJING D VENTUREPHARM TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap